Summary

Eligibility
for people ages 18 years and up (full criteria)
Location
at UCLA
Dates
study started
completion around
Principal Investigator
by Steven Farley (ucla)

Description

Summary

The Zenith® p-Branch® Pivotal Study is a clinical trial approved by FDA to study the safety and effectiveness of the Zenith® p-Branch® endovascular graft in combination with the Atrium iCAST™ covered stents in the treatment of abdominal aortic aneurysms.

Official Title

Zenith® p-Branch® Pivotal Study

Keywords

Aortic Aneurysm Abdominal, Abdominal aortic aneurysm, Endovascular, Juxtarenal, Pararenal, Fenestrated, Aneurysm, Aortic Aneurysm, Zenith® p-Branch® in combination with the Atrium iCAST™ covered stents

Eligibility

Locations

  • Ronald Reagan UCLA Medical Center
    Los Angeles California 90024 United States
  • Kaiser Permanente
    San Francisco California 94115 United States
  • Stanford University Medical School
    Stanford California 94305 United States

Lead Scientist at University of California Health

  • Steven Farley (ucla)
    Hs Clinical Professor, Surgery, Medicine. Authored (or co-authored) 24 research publications

Details

Status
in progress, not accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
Cook Research Incorporated
ID
NCT02396199
Study Type
Interventional
Participants
About 80 people participating
Last Updated